The latest official data show that smoking is one of the leading factors in the development of cardiovascular diseases among Australians.
Inclusion of Zyban into the Register of Therapeutic Goods contributed to the introduction in Australia of a new effective drug that reduces the craving for tobacco and facilitates smoking cessation.
As shown by clinical studies, the drug helps to significantly reduce nicotine dependence and prevent symptoms of withdrawal syndrome.
Zyban does not contain nicotine, it works differently than the drugs of nicotine replacement therapy, and this drug quite effectively reduces the withdrawal syndrome, as well as the craving for smoking.
Thus, the process of quitting smoking will pass without stress, in conditions comfortable for a smoker.
Supplies of Zyban in Australia are provided by two companies – Aspen and GlaxoSmithKline. The drug is available in local pharmacy chains in the form of 150 mg sustained release tablets.
Zyban tablets are covered with a white film shell and have a round shape. One side of the tablets has the “GX CH7” encoding, and the other side has no inscriptions.
Sustained release tablets Zyban are packed in blisters and are supplied in 30, 60 or 90 pieces per pack. If necessary, you can purchase a trial package of the drug in a retail drug store. Such pack usually contains 3 or 10 tablets.
If you buy a trial Zyban package, you can check the drug for tolerability. If you tolerate the drug well, without side effects, you can continue your anti-smoking treatment with Zyban.
The effect of Zyban is based on the effect of the active component over the brain structures that are responsible for obtaining pleasure. As a result, the drug suppresses psychological dependence on tobacco.
In addition, Zyban (Bupropion) is similar in structure to amphetamines, so this drug is assigned code S4 in Australia. This means that the drug is released from pharmacy chains only by prescription.
As pointed out by Australians, who used Zyban, the systematic use of tablets gives a person a lot of strength and energy, raises his mood and reduces appetite. At that, the drug does not promote a disgust for smoking, yet it reduces the severity of symptoms in withdrawal syndrome.
Since Zyban action does not onset immediately, it is used according to a certain scheme. If you have not yet taken this medication, you should know that you should not divide or crush sustained release tablets, otherwise you risk lowering their therapeutic effectiveness.
Zyban tablets are swallowed whole. To not let the tablet stick to the esophagus, it is recommended to administer it with a glass of water.
As already mentioned, the therapeutic effect of Zyban does not develop immediately, therefore, the drug can be combined with smoking during the first two weeks. For many people, who have tried to quit smoking before, this opportunity is regarded as a positive property of Zyban.
Wherever you buy Zyban, in Australia or in New Zealand, you should take the drug under the supervision of an experienced specialist, who can immediately notice some changes in your condition.
The anti-smoking treatment starts with one 150 mg Zyban tablet once a day, best in the morning. This dose is taken during the first 3 days. Starting from day 4, the daily dose is doubled.
For eleven days, patient takes one Zyban 150 tablet in the morning and the second one in the afternoon. An eight-hour time interval should be observed between the doses.
In the middle of the second week of Zyban SR use, you must appoint a day, in which you completely stop smoking. Cessation of smoking does not affect the dosage regimen, and you should take the drug as usual.
Even if you think that the drug is not effective enough, increasing the daily dose is not recommended. It should not exceed 2 Zyban tablets (i.e. no more than 300 mg of Bupropion). The duration of therapy is 7 to 10 weeks.
Despite the fact that Zyban tablets in Australia are considered one of the best drugs for the treatment of tobacco dependence, not all Australians tolerate it.
Discomfort and side effects are observed usually at the beginning of therapy, and gradually pass in 5-7 days. During this period, patients may experience dizziness, mood swings, decreased appetite, excessive excitability or persistent drowsiness.
If unwanted reactions do not disappear and transit into a chronic form, Zyban should be discontinued and the patient should consult a specialist for help.
Very rarely, the use of Zyban tablets can cause epileptic seizures. The risk of their manifestation increases if the patient had seizures before.
Therefore, patients with epilepsy in a family history and with various neoplasms of the spinal cord and brain are contraindicated to use the drug.
According to many experts, the anti-smocking drug Zyban is one of the most sought after in the market of Australia. The drug is more effective, than nicotine replacement therapy.
If you use Zyban tablets together with nicotine patches or chewing gums, your chances for success increase. The main advantage of the drug is the alleviation withdrawal syndrome symptoms and restrain of weight gain after quitting.